Abstract
Clinical trials will gauge whether GLP-1 analogs curb drug and alcohol cravings.
MeSH terms
-
Alcoholism / drug therapy
-
Anti-Obesity Agents* / pharmacology
-
Anti-Obesity Agents* / therapeutic use
-
Behavior, Addictive* / drug therapy
-
Glucagon-Like Peptide 1* / analogs & derivatives
-
Glucagon-Like Peptide 1* / pharmacology
-
Glucagon-Like Peptide 1* / therapeutic use
-
Humans
-
Substance-Related Disorders* / drug therapy
Substances
-
Anti-Obesity Agents
-
Glucagon-Like Peptide 1
-
semaglutide